The Call for Opposition: Challenging the P2P and IOM Processes
In our second article on how to react to the publication of the draft P2P report, Gabby Klein provides her view of why she and a large group of advocates and patients are continuing their protest of the government’s ongoing control and manipulation of our disease via their processes...
Discuss the article on the Forums.

Sangamo HIV drug

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by undcvr, Feb 28, 2011.

  1. undcvr

    undcvr Senior Member

    Messages:
    818
    Likes:
    167
    NYC
  2. SpecialK82

    SpecialK82 Senior Member

    Messages:
    963
    Likes:
    775
    USA
    It sounds great, it protects part of the immune system from HIV so that the immune system can work against the virus, and patients wouldn't have to take ARV's anymore, he said it would be a functional cure. Unfortunately, only in Phase 1 clinical trials and said it can take a long time to come to market.

    Thanks for posting!
     
  3. Navid

    Navid Senior Member

    Messages:
    416
    Likes:
    91
    how do you get a company like this to look at me/cfs blood/tissue too.....many of us have the same opportunistic infections as an hiv patient...we just don't die as fast.
     

See more popular forum discussions.

Share This Page